Drug intelligence / Profile preview

myelin basic protein

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous (as Peptide Sequences In Clinical Trials)
01

Overview

Myelin basic protein (MBP) is the second most abundant protein in central nervous system myelin and is essential for maintaining the structure of the myelin sheath by promoting adhesion between cytosolic surfaces of multilayered compact myelin. It belongs to the intrinsically disordered or conformationally adaptable family of proteins, meaning it lacks a stable secondary structure in solution but can adopt more defined structures upon binding to lipids or other molecules. MBP interacts with various polyanionic proteins (e.g., actin, tubulin, Ca²⁺-calmodulin, clathrin) and negatively charged lipids. Some isoforms are transported into the nucleus and may bind polynucleotides. MBP is also involved in signaling within oligodendrocytes due to changes in phosphorylation triggered by extracellular signals[1][2][5].

Other names
Myelin A1 proteinMyelin membrane encephalitogenic protein
02

Targets

SulfatideαMβ2 (Integrin αMβ2)

Beyond the preview

Go deeper on myelin basic protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on myelin basic protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call